SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-051876
Filing Date
2024-02-29
Accepted
2024-02-29 07:45:53
Documents
16
Period of Report
2024-02-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d795567d8k.htm   iXBRL 8-K 25191
2 EX-99.1 d795567dex991.htm EX-99.1 95128
6 GRAPHIC g795567g0229042431464.jpg GRAPHIC 3519
  Complete submission text file 0001193125-24-051876.txt   260662

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vrca-20240229.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20240229_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20240229_pre.xml EX-101.PRE 11262
17 EXTRACTED XBRL INSTANCE DOCUMENT d795567d8k_htm.xml XML 3613
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 24698910
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)